Zew Wajsman
About
Zew Wajsman has authored 55 papers that have received a total of 1.3k indexed citations.
This includes 23 papers in Pulmonary and Respiratory Medicine, 22 papers in Surgery and 10 papers in Oncology. The topics of these papers are Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (10 papers). Zew Wajsman is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Bladder and Urothelial Cancer Treatments (11 papers) and Urinary and Genital Oncology Studies (10 papers) and collaborates with scholars based in United States. Zew Wajsman's co-authors include Claude Merrin, Gerald P. Murphy, George Baumgartner, G.P. Murphy and Jack Saroff and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Cancer.
In The Last Decade
Fields of papers published by Zew Wajsman
Since SpecializationEngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics
Countries citing papers authored by Zew Wajsman
Since SpecializationCitations
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Ashley Frazer‐Abel Breakdown of academic impact, for papers by W. H. Goldstein Breakdown of academic impact, for papers by N. Takato Breakdown of academic impact, for papers by Hui Qiao Breakdown of academic impact, for papers by Sang Kyu Park Breakdown of academic impact, for papers by Lin Ma Breakdown of academic impact, for papers by J. L. Etchells Breakdown of academic impact, for papers by Xinqi Xu